1 Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature.

2 A global problem of epic proportions.

3 Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway.

4 Role of Tricellular Tight Junction Protein Lipolysis-Stimulated Lipoprotein Receptor (LSR) in Cancer Cells.

5 Low-Volume Nodal Metastasis in Endometrial Cancer: Risk Factors and Prognostic Significance

6 Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?

7 lymph node number predicts the efficacy of adjuvant chemoradiotherapy in node-positive endometrial cancer patients

8 psphl as a candidate gene influencing racial disparities in endometrial cancer incidence and survival

9 leukocytosis due to markedly elevated granulocyte-colony stimulating factor levels in a patient with endometrial cancer: case report and literature review

10 sentinel lymph node mapping using methylene blue and technetium-99 in early endometrial cancer

11 evaluation of the hospital environment for women with endometrial cancer

12 effect of metformin on the prognosis of diabetic patients combined with gynecologic cancer: a meta-analysis

13 endometrial adenomyoma polyp caused postmenopausal bleeding mimicking uterine malignancy

14 robot-assisted laparoscopic staging surgery for endometrial cancer—a preliminary report

15 application of laparoscopic surgery in gynecological oncology

16 the igf hormonal network in endometrial cancer: functions, regulation and targeting approaches

17 siegesbeckia orientalis extract inhibits tgfβ1-induced migration and invasion of endometrial cancer cells

18 local renin angiotensin system in the reproductive system: a review of literature

19 improved survival of patients with hypermutation in uterine serous carcinoma

20 risk of spilling cancer cells during total laparoscopic hysterectomy in low-risk endometrial cancer

21 breast cancer in the setting of fertility-sparing treatment for endometrial cancer

22 grp78 and endoplasmic reticulum stress in endometrial cancer

23 Hormonal Regulation of Patient-Derived Endometrial Cancer Stem-like Cells Generated by Three-Dimensional Culture

24 Multi-b-value diffusion weighted imaging for preoperative evaluation of risk stratification in early-stage endometrial cancer.

25 Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.

26 Pregnancy duration and endometrial cancer risk: nationwide cohort study.

27 The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol

28 PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer.

29 Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).

30 The endocrine disruptor bisphenol A promotes nuclear ERRγ translocation, facilitating cell proliferation of Grade I endometrial cancer cells via EGF-dependent and EGF-independent pathways.

31 Intercepting Endometrial Cancer: Opportunities to Expand Access Using New Technology.

32 The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry

33 Clinical significance of isolated tumor cells and micrometastasis in low-grade, stage I endometrial cancer

34 Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer

35 Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis

36 Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study

37 Low-Volume Nodal Metastasis in Endometrial Cancer: Risk Factors and Prognostic Significance

38 Lymph node micrometastases and outcome of endometrial cancer

39 Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging

40 Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review

41 tgf&beta; signaling supports survival and metastasis of endometrial cancer cells

42 utility of pelvic mri and tumor markers he4 and ca125 to predict depth of myometrial invasion and cervical involvement in endometrial cancer

43 forgotten intrauterine device wandering in the abdomen of an endometrial cancer patient

44 endophytic-type endometrial cancer with adenomyosis successfully diagnosed with hysteroscopic endometrial biopsy using an 8.3-mm operative resectoscope: a case report

45 two cases of endometrial cancer in twin sisters with myotonic dystrophy

46 a rare case of endometrial cancer metastatic to the sigmoid colon and small bowel

47 robotics in endometrial cancer care

48 molecular carcinogenesis of endometrial cancer

49 intraperitoneal fat through grp78: a risk factor for endometrial cancer

50 rapid progression of synchronous ovarian and endometrial cancers with massive omental carcinomatosis

51 endometrial thickness still presents a best reference to predict endometrial cancer

52 value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes

53 conservative management of chylous ascites following endometrial cancer staging

54 Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer?

55 Retraction NoteL“MicroRNA-373 promotes the development of endometrial cancer by targeting LATS2 and activating the Wnt/β‐Catenin pathway (J Cell Biochem., (2019), (8611-8618), 10.1002/jcb.28149)

Keyword Connections

Journals

Research Groups

Bibliographies